儿科家庭医疗保健市场规模、份额、成长分析，按服务类型、按应用、按最终用户、按地区 - 行业预测，2025 年至 2032 年

2023 年全球儿科家庭保健市场规模价值为 372 亿美元，预计将从 2024 年的 401.4 亿美元增长到 2032 年的 737.5 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.9%。

儿童因污染导致的慢性疾病（如脑性麻痹、先天性心臟疾病和癌症）的发生率不断上升，为儿科家庭医疗保健市场创造了巨大的投资机会。在美国，大约有 560 万儿童需要大量的家庭医疗护理，父母每年花费约 15 亿小时，平均每个家庭花费 3,200 美元。维持生命的家庭医疗保健服务减少了患有复杂疾病的婴幼儿的就诊次数，提高了他们的生活质量，同时降低了医疗费用。随着医学的进步，早产儿的存活时间更长、能够更早从新生儿病房出院，对专业居家照护的需求也激增，这刺激了人工呼吸器和雾化器等技术的发展，为患有慢性疾病的婴儿提供支持。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 客户和购买标准分析
• Start-Ups分析
• 专利分析

儿科家庭医疗保健市场规模（按服务类型划分）

• 市场概况
• 专业护理服务
• 个人护理协助
• 復健治疗服务
  • 物理治疗
  • 职能治疗
  • 语言治疗

儿科家庭保健市场规模（按应用）

• 市场概况
• 慢性病
  • 糖尿病
  • 气喘
  • 脑性麻痹
• 急性病
  • 呼吸道感染疾病
  • 胃肠道疾病
• 术后护理
• 安宁疗护

儿科家庭医疗保健市场规模（按最终用户划分）

• 市场概况
• 医院
• 居家照护环境
• 小儿科诊所

儿科家庭医疗保健市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• AstraZeneca plc（United Kingdom）
• Pfizer Inc.（United States）
• Sanofi SA（France）
• Boehringer Ingelheim GmbH（Germany）
• Eisai Co., Ltd.（Japan）
• Gilead Sciences, Inc.（United States）
• GlaxoSmithKline plc（United Kingdom）
• Merck & Co., Inc.（United States）
• Novartis AG（Switzerland）
• Johnson & Johnson（United States）
• Eli Lilly and Company（United States）
• Bristol-Myers Squibb Company（United States）
• Amedisys Inc.（United States）
• Maxim Healthcare Services（United States）
• Cardinal Health, Inc.（United States）
• B. Braun Melsungen AG（Germany）
• Team Select Home Care（United States）
• Portea Medical（India）

结论和建议

Global Pediatric Home Healthcare Market size was valued at USD 37.2 billion in 2023 and is poised to grow from USD 40.14 billion in 2024 to USD 73.75 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).

The growing prevalence of pediatric pollution-related chronic disorders, such as cerebral palsy, congenital heart issues, and cancer, has created significant investment opportunities in the pediatric home healthcare market. In the U.S., approximately 5.6 million children require extensive in-home medical care, leading to an annual parental commitment of around 1.5 billion hours, costing households an average of $3,200 each. Life-sustaining home healthcare services have reduced hospital visits for infants with complex conditions, enhancing their quality of life while also decreasing medical expenses. With medical advancements improving the life expectancy of preterm infants and enabling their earlier discharge from neonatal units, the demand for specialized in-home care has surged, further fueled by technologies such as ventilators and nebulizers that support infants with chronic illnesses.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pediatric Home Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pediatric Home Healthcare Market Segmental Analysis

Global Pediatric Home Healthcare Market is segmented by Service Type, Application, End-User and region. Based on Service Type, the market is segmented into Skilled Nursing Services, Personal Care Assistance and Rehabilitation Therapy Services. Based on Application, the market is segmented into Chronic Diseases, Acute Illnesses, Post-Surgical Care and Palliative Care. Based on End-User, the market is segmented into Hospitals, Home Care Settings and Pediatric Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pediatric Home Healthcare Market

The global Pediatric Home Healthcare market is driven by several key factors, notably advancements in medical interventions that have improved the life expectancy of premature infants and favorable insurance policies that facilitate access to care. The rise in chronic conditions among children, such as muscular dystrophy, epilepsy, congenital heart diseases, cystic fibrosis, cerebral palsy, and cancer, further fuels market growth. Additionally, the advent of innovative technologies in healthcare systems, particularly in developing nations, is expected to enhance service delivery. However, challenges such as the high cost of services and the need for adequately trained pediatric home healthcare nurses may restrict market expansion.

Restraints in the Global Pediatric Home Healthcare Market

The Global Pediatric Home Healthcare market faces significant constraints, particularly related to costs and workforce training. A recent survey revealed that the typical daily expense for skilled nursing services in private residences amounts to $290, while semi-private facilities charge an average of $255 per day. This discrepancy highlights the financial burden on families seeking quality pediatric care. Additionally, pediatric home care providers encounter difficulties in ensuring that their nursing staff receive adequate training to deliver exceptional care tailored to children with special needs. These factors pose challenges that can hinder the growth and accessibility of pediatric home healthcare services.

Market Trends of the Global Pediatric Home Healthcare Market

The Global Pediatric Home Healthcare market is poised for significant growth as the aftermath of the COVID-19 pandemic amplifies the demand for accessible and affordable healthcare solutions. Families increasingly favor home care services as safe alternatives to traditional hospital visits, motivated by safety concerns and cost-effectiveness. The rising prevalence of chronic conditions among children further accelerates this trend, necessitating continuous medical attention in a familiar environment. Additionally, the limited threat posed by informal care and expensive healthcare facilities ensures a favorable market landscape, positioning pediatric home healthcare as a reliable solution in the evolving healthcare ecosystem.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Startup Analysis
• Patent Analysis

Global Pediatric Home Healthcare Market Size by Service Type & CAGR (2025-2032)

• Market Overview
• Skilled Nursing Services
• Personal Care Assistance
• Rehabilitation Therapy Services
  • Physical Therapy
  • Occupational Therapy
  • Speech Therapy

Global Pediatric Home Healthcare Market Size by Application & CAGR (2025-2032)

• Market Overview
• Chronic Diseases
  • Diabetes
  • Asthma
  • Cerebral Palsy
• Acute Illnesses
  • Respiratory Infections
  • Gastrointestinal Disorders
• Post-Surgical Care
• Palliative Care

Global Pediatric Home Healthcare Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Care Settings
• Pediatric Specialty Clinics

Global Pediatric Home Healthcare Market Size & CAGR (2025-2032)

• North America (Service Type, Application, End-User)
  • US
  • Canada
• Europe (Service Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AstraZeneca plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amedisys Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Maxim Healthcare Services (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Team Select Home Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Portea Medical (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations